Comparison of patients using lamivudine, entecavir, and tenofovir according to liver fibrosis markers fibrosis-4 and aspartate aminotransferase-to-platelet ratio index scores
CONCLUSION: Consistent with the study outcome, when we consider FIB regression, tenofovir and entecavir regimens were found more effective than lamivudine. In addition, entecavir was more effective than the other two drugs after the 1st year.
Source: Indian Journal of Pharmacology - Category: Drugs & Pharmacology Authors: Huseyin Dogus Okan Oguz Karabay Ertugrul Guclu Mustafa Baran Inci Aziz Ogutlu Source Type: research
More News: Drugs & Pharmacology | Hepatitis | Hepatitis B | India Health | Liver | Statistics | Study | Urology & Nephrology | Viread